Modulation of Hippocampal Hyperactivity in Schizophrenia With Levetiracetam: a Randomized, Double-Blind, Cross-Over, Placebo-Controlled Trial

被引：0
|
作者：
Roeske, Maxwell [1 ]
McHugo, Maureen [1 ]
Rogers, Baxter [1 ]
Avery, Suzanne [1 ]
Armstrong, Kristan [1 ]
Heckers, Stephan [1 ]
机构：
[1] Vanderbilt Univ, Med Ctr, Nashville, TN USA
来源：
NEUROPSYCHOPHARMACOLOGY | 2023年 / 48卷
关键词：
Hippocampus; Schizophrenia (SCZ); Functional Neuroimaging; Clinical Trial; Levetiracetam;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
P494
引用
收藏
页码：350 / 351
页数：2
相关论文
共 50 条
  • [21] Nicotine and Behavioral Markers of Risk for Schizophrenia: A Double-Blind, Placebo-Controlled, Cross-Over Study
    Lana Dépatie
    Gillian A O′Driscoll
    Anne-Lise V Holahan
    Victoria Atkinson
    Joseph X Thavundayil
    N Ng Ying Kin
    Samarthji Lal
    Neuropsychopharmacology, 2002, 27 : 1056 - 1070
  • [22] A Randomized Double-blind, Placebo-controlled, Cross-over Trial of Ganaxolone in Children and Adolescents with Fragile X Syndrome
    Tsai, Julia
    Ligsay, Andrew
    Van Dijck, Anke
    Kooy, Frank
    Hessl, David
    Bickel, Erika
    Hagerman, Randi
    Patroneva, Albena
    NEUROLOGY, 2017, 88
  • [23] Safety and efficacy of creatine supplementation in juvenile dermatomyositis: a randomized double-blind placebo-controlled cross-over trial
    Adriana Sallum
    Marina Solis
    Ana Paula Hayashi
    Guilherme Artioli
    Marcelo Sapienza
    Maria Otaduy
    Ana Pinto
    Clóvis Silva
    Rosa Pereira
    Bruno Gualano
    Pediatric Rheumatology, 12 (Suppl 1)
  • [24] A double-blind, placebo controlled, cross-over trial of adjunctive donepezil for cognitive impairment in schizophrenia
    Tugal, O
    Yazici, KM
    Yagcioglu, AEA
    Gogus, A
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 (02): : 117 - 123
  • [25] Treatment of internuclear ophthalmoparesis in multiple sclerosis with fampridine: A randomized double-blind, placebo-controlled cross-over trial
    Kanhai, Kawita M. S.
    Bijvank, Jenny A. Nij
    Wagenaar, Yorick L.
    Klaassen, Erica S.
    Lim, KyoungSoo
    Bergheanu, Sandrin C.
    Petzold, Axel
    Verma, Ajay
    Hesterman, Jacob
    Wattjes, Mike P.
    Uitdehaag, Bernard M. J.
    van Rijn, Laurentius J.
    Groeneveld, Geert Jan
    CNS NEUROSCIENCE & THERAPEUTICS, 2019, 25 (06) : 697 - 703
  • [26] LITHIUM ADDITION TO NEUROLEPTIC TREATMENT IN CHRONIC-SCHIZOPHRENIA - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, CROSS-OVER STUDY
    TERAO, T
    OGA, T
    NOZAKI, S
    OHTA, A
    OHTSUBO, Y
    YAMAMOTO, S
    ZAMAMI, M
    OKADA, M
    ACTA PSYCHIATRICA SCANDINAVICA, 1995, 92 (03) : 220 - 224
  • [27] High dose gabapentin for essential tremor: A double-blind, placebo-controlled, cross-over trial
    Jankovic, JJ
    Hunter, C
    Schwartz, K
    Ondo, WG
    NEUROLOGY, 1999, 52 (06) : A456 - A456
  • [28] LAMOTRIGINE THERAPY FOR PARTIAL SEIZURES - A MULTICENTER, PLACEBO-CONTROLLED, DOUBLE-BLIND, CROSS-OVER TRIAL
    MESSENHEIMER, J
    RAMSAY, RE
    WILLMORE, LJ
    LEROY, RF
    ZIELINSKI, JJ
    MATTSON, R
    PELLOCK, JM
    VALAKAS, AM
    WOMBLE, G
    RISNER, M
    EPILEPSIA, 1994, 35 (01) : 113 - 121
  • [29] AMLODIPINE IN PATIENTS WITH ANGINA UNCONTROLLED BY ATENOLOL - A DOUBLE-BLIND PLACEBO-CONTROLLED CROSS-OVER TRIAL
    WOODMANSEY, PA
    STEWART, AG
    MORICE, AH
    CHANNER, KS
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 45 (02) : 107 - 111
  • [30] DIPYRIDAMOLE FOR THE TREATMENT OF RLS: PRELIMINARY RESULTS OF A CROSS-OVER, PLACEBO-CONTROLLED, DOUBLE-BLIND TRIAL
    Garcia-Borreguero, D.
    Granizo, J.
    Ferre, S.
    SLEEP, 2020, 43 : A303 - A303
12345